Shares of vaccine and mpox-related stocks are trading higher on continued strength after the WHO last week declared the virus a global health emergency.
Portfolio Pulse from Benzinga Newsdesk
Shares of vaccine and mpox-related stocks are trading higher following the WHO's declaration of the virus as a global health emergency last week.
August 19, 2024 | 12:16 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Emergent BioSolutions (EBS) shares are trading higher due to increased demand for vaccines following the WHO's declaration of mpox as a global health emergency.
The WHO's declaration is likely to increase demand for vaccines, benefiting companies like Emergent BioSolutions that are involved in vaccine production.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
GeoVax Labs (GOVX) shares are trading higher as the WHO's global health emergency declaration for mpox boosts interest in vaccine-related stocks.
GeoVax Labs is likely to see increased investor interest and potential demand for its vaccine-related products following the WHO's declaration.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Virax Biolabs (VRAX) shares are trading higher on the back of the WHO's declaration of mpox as a global health emergency, which is driving up vaccine-related stocks.
Virax Biolabs is expected to benefit from increased demand and investor interest in vaccine-related products following the WHO's declaration.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80